Koninklijke DSM NV (KDSKF.PK)

KDSKF.PK on OTC Markets Group - US Other OTC and Grey Market

58.79USD
19 Jun 2015
Change (% chg)

-- (--)
Prev Close
$58.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
272
52-wk High
$72.00
52-wk Low
$49.50

KDSKF.PK

Chart for KDSKF.PK

About

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in health, nutrition and materials. The Company operates in segments: Nutrition, Performance Materials, Polymer Intermediates, Innovation Center and Corporate Activities. DSM Nutritional Products is the supplier of essential nutrients, such as vitamins,... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €9,397.82
Shares Outstanding(Mil.): 181.43
Dividend: 1.10
Yield (%): 3.19

Financials

  KDSKF.PK Industry Sector
P/E (TTM): 101.29 34.68 20.16
EPS (TTM): 0.51 -- --
ROI: 1.34 6.88 14.14
ROE: 1.51 7.70 15.90
Search Stocks

BRIEF-DSM and Medday to produce pharmaceutical grade D-Biotin

* Medday and DSM announce a partnership to produce pharmaceutical grade D-Biotin to treat progressive multiple sclerosis

17 Jun 2015

BRIEF-Koninklijke DSM announces joint venture with Sobisco in India

* Announces joint venture with Sobisco to produce fortified foods and beverages for Eastern India

05 Jun 2015

UPDATE 2-Top EU companies urge drastic cuts in greenhouse gas emissions

* Want tough action from Paris U.N. summit in December (Updates with quotes from Kerry, Fabius, DSM)

21 May 2015

BRIEF-DSM finalizes sale of DSM Synres to Standard Investment

* DSM Synres realizes sales of about 50 mln euro with around 80 employees

02 Apr 2015

UPDATE 1-DSM sells 65 percent stake in chemicals to CVC for at least 300 mln euros

* Deal will refocus company on less cyclical nutrition businesses

16 Mar 2015

DSM sells polymers, resins stake to CVC for at least 300 mln euros

AMSTERDAM, March 16 - Dutch supplements maker DSM said on Monday it will sell a 65 percent stake in two of its chemicals subsidiaries to CVC Capital Partners for at least 300 million euros ($316 million) in cash.

16 Mar 2015

BRIEF-DSM says CVC to invest in polymer intermediates, composite resins units

* Dsm and cvc announce partnership for polymer intermediates and composite resins

16 Mar 2015

UPDATE 2-DSM expects 2015 uplift despite low vitamin E prices and currency effects

* To combine 3 non-core units ahead of possible strategic actions

11 Feb 2015

DSM promises stronger 2015 despite low vitamin E prices, currency effects

AMSTERDAM, Feb 11 - DSM, a Dutch life sciences, materials and nutrition company, said it expected 2015 earnings to be higher than last year's despite low Vitamin E prices and negative currency effects, after posting fourth-quarter earnings and sales slightly ahead of estimates.

11 Feb 2015

Earnings vs. Estimates

Search Stocks